As for the increase in the AST/ALT ratio often observed in patients with small cell lung cancer (SCLC), this may be due to the distinct characteristics of SCLC, which is generally more aggressive than other lung cancer types. The gene discussed is GPT; the disease is small cell lung carcinoma.